These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tumor suppressor gene mutations in mice. Jacks T Annu Rev Genet; 1996; 30():603-36. PubMed ID: 8982467 [TBL] [Abstract][Full Text] [Related]
5. Human cancer syndromes: clues to the origin and nature of cancer. Fearon ER Science; 1997 Nov; 278(5340):1043-50. PubMed ID: 9353177 [TBL] [Abstract][Full Text] [Related]
6. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281 [TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor mutations in mice: the next generation. McClatchey AI; Jacks T Curr Opin Genet Dev; 1998 Jun; 8(3):304-10. PubMed ID: 9690995 [TBL] [Abstract][Full Text] [Related]
9. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors]. Müller H; Scott RJ Schweiz Med Wochenschr; 1995 Jul; 125(30):1445-54. PubMed ID: 7676234 [TBL] [Abstract][Full Text] [Related]
10. Facts in cancer genetics. Cornelisse CJ; Devilee P Patient Educ Couns; 1997; 32(1-2):9-17. PubMed ID: 9355568 [TBL] [Abstract][Full Text] [Related]
11. Genes associated with tumor suppression and growth control in the human nervous system. Seizinger BR Cancer Metastasis Rev; 1991 Dec; 10(4):281-7. PubMed ID: 1786629 [TBL] [Abstract][Full Text] [Related]
12. Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndrome. Andersson MK; Kölby L; Nilsson JA; Stenman G J Plast Surg Hand Surg; 2019 Apr; 53(2):71-75. PubMed ID: 30676842 [TBL] [Abstract][Full Text] [Related]
13. [Cancer genetics of TSC2 gene mutant(Eker) rat model]. Hino O Nihon Rinsho; 2000 Jun; 58(6):1255-61. PubMed ID: 10879050 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations underlying colorectal tumorigenesis. Fearon ER Cancer Surv; 1992; 12():119-36. PubMed ID: 1638544 [TBL] [Abstract][Full Text] [Related]
15. Studies of oncogene activation and tumor suppressor gene inactivation in normal and neoplastic rodent tissue. Buzard GS Mutat Res; 1996 Sep; 365(1-3):43-58. PubMed ID: 8898988 [TBL] [Abstract][Full Text] [Related]
17. Role of tumor suppressor genes in a multistep model of carcinogenesis. Boyd JA; Barrett JC Basic Life Sci; 1991; 57():183-94; discussion 194-6. PubMed ID: 1814282 [No Abstract] [Full Text] [Related]
18. Heterozygous Tumor Suppressor Microenvironment in Cancer Development. Brosseau JP; Le LQ Trends Cancer; 2019 Sep; 5(9):541-546. PubMed ID: 31474359 [TBL] [Abstract][Full Text] [Related]
19. The p53-deficient mouse: a model for basic and applied cancer studies. Donehower LA Semin Cancer Biol; 1996 Oct; 7(5):269-78. PubMed ID: 9110404 [TBL] [Abstract][Full Text] [Related]
20. [Genetic factors involved in cancer susceptibility]. Kohno T; Yokota J Gan To Kagaku Ryoho; 2002 Jul; 29(7):1255-62. PubMed ID: 12146010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]